Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Affimed Therapeutics (Germany) | Researchclopedia

Back to institutions

Affimed Therapeutics (Germany)

Heidelbergcompany

208

Works

30,442

Citations

79

h-index

Top Research Topics

Monoclonal and Polyclonal Antibodies Research CAR-T cell therapy research Immune Cell Function and Interaction

Top Researchers

Benjamin L. Ebert RWTH Aachen University

765 works153,443 citationsh-index: 122

Recent Research

NK cell-mediated tumor cell killing by bispecific innate cell engagers induces ADCC-mediated activation of primary human dendritic cells

Lukas Andreas Heger,Tomasz Kaszubowski,et al.

20260 citations

Lymphoma Diagnosis and Treatment

Glycosylation and Glycoproteins Research

Cancer Immunotherapy and Biomarkers

Immunotherapy and Immune Responses

T-cell and B-cell Immunology

HER2/EGFR in Cancer Research

Cell Adhesion Molecules Research

Chronic Lymphocytic Leukemia Research

Radiopharmaceutical Chemistry and Applications

Donna Neuberg Dana-Farber Cancer Institute

1,701 works101,383 citationsh-index: 155

Thomas E. Witzig Toyota Motor Corporation (Switzerland)

1,273 works61,973 citationsh-index: 129

Jerome Ritz Boston University

1,196 works60,277 citationsh-index: 128

Stephen J. Forman City Of Hope National Medical Center

1,782 works59,773 citationsh-index: 127

James R. Cerhan Mayo Clinic

1,279 works55,176 citationsh-index: 113

An oral, liver-restricted LXR inverse agonist for dyslipidemia: preclinical development and phase 1 trial

Xiaoxu Li,Giorgia Benegiamo,et al.

20261 citations

Selective class IIa HDAC inhibition reverses diastolic dysfunction in cardiometabolic HFpEF

Jiale Huang,Friederike Schreiter,et al.

20260 citations

Innate Immune Cell Engagers: Matchmakers for Next-Generation Immunotherapy

Sascha Cording,Jens Pahl,et al.

20250 citations

P2.06.100 Initial Biomarker Results From the Phase 2A Study of AFM24 With Atezolizumab in Patients With Advanced/Metastatic NSCLC

H.R. Kim,A. Oberoi,et al.

20250 citations

CD16A Shedding Regulates Innate Cell Engager‐Induced Serial Killing by Natural Killer Cells

Chiara Zambarda,Karolin Guldevall,et al.

20253 citations